Jolanta M. Siller-Matula

Department of Internal Medicine II, Medical University of Vienna

Affiliated withMedical University of Vienna Medical University of Warsaw, Center for Preclinical Research and Technology CEPT

Research Area

Medicine

Biography

Jolanta M. Siller-Matula has not added Biography.
If you are Jolanta M. Siller-Matula and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2021

Other Publications

Article	Year
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Heart (British Cardiac Society)\| PubMed ID: 20736210	2011
Interspecies differences in coagulation profile. Thrombosis and haemostasis\| PubMed ID: 18766254	2008
Reproducibility and standardized reporting of the vasodilator-stimulated phosphoprotein phosphorylation assay. Platelets\| PubMed ID: 18979368	2008
Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. Journal of the American College of Cardiology\| PubMed ID: 19007592	2008
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. American heart journal\| PubMed ID: 19081411	2009
The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation. Thrombosis research\| PubMed ID: 19135705	2009
Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers. Thrombosis and haemostasis\| PubMed ID: 19652892	2009
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. British journal of pharmacology\| PubMed ID: 20050853	2010
The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo. Transfusion\| PubMed ID: 20070617	2010
An experimental model to study isolated effects of thrombin in vivo. Thrombosis research\| PubMed ID: 20869757	2010
Targeting von Willebrand factor and platelet glycoprotein Ib receptor. Expert review of cardiovascular therapy\| PubMed ID: 21108551	2010
Ticagrelor: from discovery to Phase III clinical trial. Future cardiology\| PubMed ID: 21142630	2010
Addition of omeprazole to dual antiplatelet therapy with clopidogrel plus aspirin lowers the risk of upper gastrointestinal bleeding. Evidence-based medicine\| PubMed ID: 21558563	2011
Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects. Thrombosis and haemostasis\| PubMed ID: 21979864	2011
The effect of erythropoietin on platelet and endothelial activation markers: a prospective trial in healthy volunteers. Platelets\| PubMed ID: 22098110	2012
ARC15105 is a potent antagonist of von Willebrand factor mediated platelet activation and adhesion. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 22282355	2012
Continuous thrombin infusion leads to a bleeding phenotype in sheep. Thrombosis research\| PubMed ID: 22289207	2012
Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin. International journal of cardiology\| PubMed ID: 22305813	2013
Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial. Clinical science (London, England : 1979)\| PubMed ID: 22646240	2012
Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study. International journal of cardiology\| PubMed ID: 22656044	2013
Why have studies of tailored anti-platelet therapy failed so far? Thrombosis and haemostasis\| PubMed ID: 23884166	2013
Response variability to P2Y12 receptor inhibitors: expectations and reality. JACC. Cardiovascular interventions\| PubMed ID: 24262612	2013
Association between the rs342293 polymorphism and adverse cardiac events in patients undergoing percutaneous coronary intervention. Thrombosis and haemostasis\| PubMed ID: 24652536	2014
[Dual platelet inhibitors in intensive care units]. Medizinische Klinik, Intensivmedizin und Notfallmedizin\| PubMed ID: 24986549	2014
Interplay between genetic and clinical variables affecting platelet reactivity and cardiac adverse events in patients undergoing percutaneous coronary intervention. PloS one\| PubMed ID: 25051347	2014
The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention. Clinical science (London, England : 1979)\| PubMed ID: 25124236	2015
How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer? Thrombosis and haemostasis\| PubMed ID: 25231675	2015
Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry. BMJ open\| PubMed ID: 25361837	2014
Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (PREDICT-STABLE). PloS one\| PubMed ID: 25799149	2015
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. European heart journal\| PubMed ID: 25896078	2015
Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. European heart journal. Acute cardiovascular care\| PubMed ID: 25943554	2017
Inter-patient variability of platelet reactivity in patients treated with prasugrel and ticagrelor. Platelets\| PubMed ID: 26555925	2016
Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology\| PubMed ID: 26677375	2015
Distribution of clinical events across platelet aggregation values in all-comers treated with prasugrel and ticagrelor. Vascular pharmacology\| PubMed ID: 26804766	2016
Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients. British journal of clinical pharmacology\| PubMed ID: 27366874	2016
Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study. International journal of cardiology\| PubMed ID: 27810295	2017
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. European heart journal. Cardiovascular pharmacotherapy\| PubMed ID: 28204303	2017
Platelets redox balance assessment: Current evidence and methodological considerations. Vascular pharmacology\| PubMed ID: 28684282	2017
Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention. Thrombosis and haemostasis\| PubMed ID: 28726980	2017
Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (vention o Th... Journal of the American Heart Association\| PubMed ID: 28736385	2017
Clopidogrel in Critically Ill Patients. Clinical pharmacology and therapeutics\| PubMed ID: 28913918	2018
Ticagrelor - toward more efficient platelet inhibition and beyond. Therapeutics and clinical risk management\| PubMed ID: 29398917	2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consort... American heart journal\| PubMed ID: 29653637	2018
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy. International journal of cardiology\| PubMed ID: 29706429	2018
Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires? Current medical research and opinion\| PubMed ID: 30091642	2019
Coming Closer to Personalized Medicine in Transcatheter Aortic Valve Replacement. JACC. Cardiovascular interventions\| PubMed ID: 30190062	2018
Cangrelor Induces More Potent Platelet Inhibition without Increasing Bleeding in Resuscitated Patients. Journal of clinical medicine\| PubMed ID: 30445678	2018
Switching between P2Y antagonists - From bench to bedside. Vascular pharmacology\| PubMed ID: 30685502	2019
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies. International journal of cardiology\| PubMed ID: 30777407	2019
Platelet reactivity patterns in patients treated with dual antiplatelet therapy. European journal of clinical investigation\| PubMed ID: 30882911	2019
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI: A Meta-Analysis. Thrombosis and haemostasis\| PubMed ID: 30919382	2019
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - Euro... BMJ open\| PubMed ID: 30928922	2019
[Aortic valve disease]. MMW Fortschritte der Medizin\| PubMed ID: 30937769	2019
Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review. Clinical pharmacology and therapeutics\| PubMed ID: 31055838	2019
Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study. Scientific reports\| PubMed ID: 31160687	2019
Shedding Light on Long-Term Effects of Early Antiplatelet Strategies After Fibrinolytic Treatment in STEMI. Journal of the American College of Cardiology\| PubMed ID: 31171088	2019
Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers. Clinical pharmacology and therapeutics\| PubMed ID: 31442298	2020
Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review. Cardiovascular diabetology\| PubMed ID: 31470851	2019
Transcatheter Aortic Valve Replacement Is Associated with Less Oxidative Stress and Faster Recovery of Antioxidant Capacity than Surgical Aortic Valve Replacement. Journal of clinical medicine\| PubMed ID: 31480644	2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. European heart journal. Cardiovascular pharmacotherapy\| PubMed ID: 31504375	2020
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups. BMC medicine\| PubMed ID: 31679516	2019
Bioresorbable Vascular Scaffolds-Dead End or Still a Rough Diamond? Journal of clinical medicine\| PubMed ID: 31817876	2019
Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel. Journal of thrombosis and haemostasis : JTH\| PubMed ID: 31833175	2020
Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing. Frontiers in cardiovascular medicine\| PubMed ID: 31850373	2019
Transcatheter versus surgical aortic valve replacement in low-risk patients: a meta-analysis of randomized trials. Clinical research in cardiology : official journal of the German Cardiac Society\| PubMed ID: 31863174	2020
Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. European heart journal\| PubMed ID: 31876924	2020
Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis. Clinical pharmacology and therapeutics\| PubMed ID: 31990051	2020
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardio... European heart journal. Cardiovascular pharmacotherapy\| PubMed ID: 32049278	2020
Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis. Atherosclerosis\| PubMed ID: 32126388	2020
Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particu... Journal of clinical medicine\| PubMed ID: 32295160	2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium. Clinical pharmacology and therapeutics\| PubMed ID: 32472697	2020
Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS. Platelets\| PubMed ID: 32501749	2020
Prediction for Contrast Volume in Transcatheter Aortic Valve Replacement - Important but Modifiable? Cardiology\| PubMed ID: 32506061	2020
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients. European journal of clinical investigation\| PubMed ID: 32506444	2020
Adaptive development of concomitant secondary mitral and tricuspid regurgitation after transcatheter aortic valve replacement. European heart journal cardiovascular Imaging\| PubMed ID: 32561917	2020
Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology\| PubMed ID: 32636896	2020
von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo. Thrombosis and haemostasis\| PubMed ID: 32679592	2020
Medication adherence and its determinants in patients after myocardial infarction. Scientific reports\| PubMed ID: 32694522	2020
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Regis... Internal and emergency medicine\| PubMed ID: 32955677	2020
Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome. Vascular pharmacology\| PubMed ID: 33035661	2020
MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease: New and Potential Therapeutic Targets. Cardiology clinics\| PubMed ID: 33036721	2020
MicroRNAs as Biomarkers of Systemic Changes in Response to Endurance Exercise-A Comprehensive Review. Diagnostics (Basel, Switzerland)\| PubMed ID: 33066215	2020
Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines. Cardiology journal\| PubMed ID: 33073857	2020
Cardiac arrest and related mortality in emergency departments in the United States: Analysis of the nationwide emergency department sample. Resuscitation\| PubMed ID: 33086085	2020
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. Journal of clinical medicine\| PubMed ID: 33233425	2020
Editorial: Antithrombotic Treatment in Transcatheter Structural Cardiac Interventions and After Cardiac Device Implantation. Frontiers in cardiovascular medicine\| PubMed ID: 33282921	2020
Right ventricular function and outcome in patients undergoing transcatheter aortic valve replacement. European heart journal cardiovascular Imaging\| PubMed ID: 33377480	2020
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease: A Systematic Review and Meta-Analysi... American journal of therapeutics\| PubMed ID: 33395057	2020
Sex Differences in Treatment and Outcomes in Non-ST-Elevation Acute Coronary Syndrome: A Persistent Disparity. Circulation. Cardiovascular interventions\| PubMed ID: 33430605	2021